ABI-H0731
|
|
ABI-H0731 Eigenschaften
- Siedepunkt:
- 566.3±50.0 °C(Predicted)
- Dichte
- 1.557±0.06 g/cm3(Predicted)
- storage temp.
- Store at -20°C
- L?slichkeit
- DMSO : 100 mg/mL (213.93 mM; Need ultrasonic)
- Aggregatzustand
- Solid
- pka
- 11.14±0.20(Predicted)
- Farbe
- White to off-white
Sicherheit
ABI-H0731 Chemische Eigenschaften,Einsatz,Produktion Methoden
ABI-H0731 Upstream-Materialien And Downstream Produkte
Upstream-Materialien
Downstream Produkte
ABI-H0731 Anbieter Lieferant Produzent Hersteller Vertrieb H?ndler.
Global( 29)Lieferanten
Firmenname | Telefon | Land | Produktkatalog | Edge Rate | |
---|---|---|---|---|---|
Henan Tianfu Chemical Co.,Ltd. | +86-0371-55170693 +86-19937530512 |
info@tianfuchem.com | China | 21628 | 55 |
TargetMol Chemicals Inc. | +1-781-999-5354 +1-00000000000 |
marketing@targetmol.com | United States | 32267 | 58 |
TargetMol Chemicals Inc. | |
support@targetmol.com | United States | 38660 | 58 |
Aladdin Scientific | |
tp@aladdinsci.com | United States | 57505 | 58 |
Shanghai YuanQi Biotechnology Co., Ltd. | +86-2332782371 +86-18120098618 |
sales@adobechem.com | China | 1250 | 50 |
Shanghai Lollane Biological Technology Co.,Ltd. | 021-52996696,15000506266 15000506266 |
China | 4611 | 55 | |
Shanghai EFE Biological Technology Co., Ltd. | 021-65675885 18964387627 |
info@efebio.com | China | 9803 | 58 |
Shanghai YuanYe Biotechnology Co., Ltd. | 021-61312847; 18021002903 |
3008007409@qq.com | China | 71829 | 60 |
ShangHai Biochempartner Co.,Ltd | 17754423994 17754423994 |
2853530910@QQ.com | China | 8011 | 62 |
Shanghai Chaolan Chemical Technology Center | 021-QQ:65489617 15618227136 |
Sales@ATKchemical.com | China | 9342 | 58 |
- ABI-H0731
- 11-oxo-N-((2-(trifluoromethyl)thiazol-5-yl)methyl)-10,11-dihydrodibenzo[b,f][1,4]thiazepine-8-carboxamide-5,5-dioxide
- Dibenzo[b,f][1,4]thiazepine-8-carboxamide, 10,11-dihydro-11-oxo-N-[[2-(trifluoromethyl)-5-thiazolyl]methyl]-, 5,5-dioxide
- antiviral,Inhibitor,Vebicorvir,inhibit,Hepatitis B virus,HBV,CHB,DBT
- 5,5,11-Trioxo-10,11-dihydro-5H-dibenzo[b,f][1,4]thiazepine-8-carboxylic acid (2-trifluoromethyl-thiazol-5-ylmethyl)-amide
- 2,2,10-trioxo-N-{[2-(trifluoromethyl)-1,3-thiazol-5-yl]methyl}-2λ?-thia-9-azatricyclo[9.4.0.03,?]pentadeca-1(11),3(8),4,6,12,14-hexaene-6-carboxamide
- Vebicorvir, 10 mM in DMSO
- 2090064-66-5
- C19H12F3N3O4S2